Target Audience: This activity is designed for mental health and addiction treatment professionals, integrated care providers, and medical staff. This activity is accredited for nurses, physicians, physician assistants, social workers, pharmacists, interprofessional teams, and other health professionals.

Webinar Description: Suicide is a leading cause of death in the United States, with provisional estimates of over 47,000 deaths in 2021. Nonetheless, the evidence shows suicide can be prevented through comprehensive healthcare and community-based strategies, as outlined in the Surgeon General’s Call to Action to Implement the National Strategy for Suicide Prevention. Substance misuse is a risk factor for suicide, and people who use opioids are at increased risk for suicidal thoughts and behaviors. This webinar will provide an overview of risk and protective factors associated with suicidality and opioid use disorder (OUD), and will outline effective organizational and clinical prevention and intervention strategies for individuals experiencing OUD.

Educational Objectives:

• Describe the broad context of suicide in the U.S. and what we know about suicide prevention.
• Examine the relationship between suicidality and opioid use disorder (OUD) from a public health standpoint.
• Leverage clinical intervention and prevention strategies and resources to address suicidality and OUD.

Continuing Education information:

In support of improving patient care, this activity has been planned and implemented by American Academy of Addiction Psychiatry (AAAP) and National Council for Mental Wellbeing (NCMW). AAAP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 Nursing Contact Hours.

PA Designation Statement

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Social Work Designation Statement

As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credit.

Interprofessional Continuing Education (IPCE) Designation Statement

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.

Pharmacy Designation Statement

This course has been approved for 1 hour of pharmacy continuing education credit. The approval number issued is Universal Activity Number: UAN JA4008192-9999-22-014-H01-P

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credits™.